Vgontzas A N, Zoumakis M, Papanicolaou D A, Bixler E O, Prolo P, Lin H-M, Vela-Bueno A, Kales A, Chrousos G P
Sleep Research and Treatment Center, Department of Psychiatry, and Health Evaluation Sciences, The Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.
Metabolism. 2002 Jul;51(7):887-92. doi: 10.1053/meta.2002.33357.
Chronic insomnia, by far the most commonly encountered sleep disorder in medical practice, is characterized by difficulty falling or staying asleep at night and increased fatigue during the day. Interleukin-6 (IL-6) and tumor necrosis factor (TNF) are fatigue-inducing cytokines, and the daytime secretion of IL-6 is negatively influenced by the quantity and quality of the previous night's sleep. We hypothesize that the poor quality of insomniacs' sleep is associated with a hypersecretion of these 2 cytokines during the daytime, which, in turn, correlates with the fatigue experienced by these patients. Eleven young insomniacs (6 men and 5 women) and 11 (8 men and 3 women) age- and body mass index (BMI)-matched healthy controls participated in the study. Subjects were recorded in the sleep laboratory for 4 consecutive nights and serial 24-hour plasma measures of IL-6 and TNF were obtained during the 4th day. Insomniacs compared to controls slept poorly (sleep latency and wake were increased, whereas percentage sleep time was decreased during baseline nights, all P <.05). The mean 24-hour IL-6 and TNF secretions were not different between insomniacs and controls. However, the difference in the change (increase) of IL-6 plasma levels from midafternoon (2 PM) to evening (9 PM) between insomniacs and controls was significant (P <.01). Furthermore, cosinor analysis showed a significant shift of the major peak of IL-6 secretion from nighttime (4 AM) to evening (7 PM) in insomniacs compared to controls (P <.05). Also, while TNF secretion in controls showed a distinct circadian rhythm with a peak close and prior to the offset of sleep (P <.05), such a rhythm was not present in insomniacs. Finally, daytime secretion of TNF in insomniacs was characterized by a regular rhythm of 4 hours (P <.05); such a distinct periodicity was not present in controls. We conclude that chronic insomnia is associated with a shift of IL-6 and TNF secretion from nighttime to daytime, which may explain the daytime fatigue and performance decrements associated with this disorder. The daytime shift of IL-6 and TNF secretion, combined with a 24-hour hypersecretion of cortisol, an arousal hormone, may explain the insomniacs' daytime fatigue and difficulty falling asleep.
慢性失眠是目前医学实践中最常见的睡眠障碍,其特征是夜间难以入睡或保持睡眠状态,且白天疲劳感加剧。白细胞介素-6(IL-6)和肿瘤坏死因子(TNF)是诱导疲劳的细胞因子,前一晚睡眠的数量和质量会对IL-6的日间分泌产生负面影响。我们推测,失眠患者睡眠质量差与这两种细胞因子在白天的分泌过多有关,而这又与这些患者所经历的疲劳感相关。11名年轻失眠患者(6名男性和5名女性)以及11名年龄和体重指数(BMI)相匹配的健康对照者(8名男性和3名女性)参与了该研究。受试者在睡眠实验室连续记录4个晚上,并在第4天获取IL-6和TNF的连续24小时血浆测量值。与对照组相比,失眠患者睡眠质量差(基线夜晚的睡眠潜伏期和觉醒时间增加,而睡眠时间百分比降低,所有P<.05)。失眠患者和对照组之间的24小时IL-6和TNF平均分泌量没有差异。然而,失眠患者和对照组之间从下午中段(下午2点)到晚上(晚上9点)IL-6血浆水平变化(增加)的差异具有显著性(P<.01)。此外,余弦分析显示,与对照组相比,失眠患者IL-6分泌的主要峰值从夜间(凌晨4点)显著转移到晚上(晚上7点)(P<.05)。同样,虽然对照组的TNF分泌呈现出明显的昼夜节律,在睡眠结束前接近峰值(P<.05),但失眠患者中不存在这种节律。最后,失眠患者的TNF日间分泌呈现出4小时的规律节律(P<.05);对照组中不存在这种明显的周期性。我们得出结论,慢性失眠与IL-6和TNF分泌从夜间转移到白天有关,这可能解释了与该疾病相关的白天疲劳和功能下降。IL-6和TNF分泌的日间转移,再加上促醒激素皮质醇的24小时分泌过多,可能解释了失眠患者的白天疲劳和入睡困难。